Sign in

You're signed outSign in or to get full access.

Tony Tian

Chief Financial Officer at Aimfinity Investment Corp. I
Executive
Board

About Tony Tian

Xuedong (Tony) Tian is Chief Financial Officer (Principal Financial and Accounting Officer) and a director of Aimfinity Investment Corp. I (AIMTF) since March 17, 2023 . He is 53 years old and holds an MBA (NYU), an MA in Economics (University of Connecticut), and MS/BS degrees from China Agricultural University; he is also a CFA charterholder . As a SPAC, Aimfinity presently has no revenue and has incurred losses since inception, so traditional operating performance metrics (revenue/EBITDA growth) and TSR-based pay-for-performance analysis are not applicable at this stage . As of the September 29, 2025 record date, the Trust Account stood at approximately $14.29 million and estimated per-share redemption value was ~$12.80, framing the company’s capital structure and incentive environment during Mr. Tian’s tenure .

Past Roles

OrganizationRoleYearsStrategic Impact
Snail, Inc. (Nasdaq: SNAL)Co-CEOSince Apr 2024Public company leadership experience in gaming/entertainment; capital markets and operating credentials .
Kingswood Capital PartnersManaging DirectorSince 2024Investment banking/capital markets leadership relevant to SPAC execution and financing .
Feutune Light Acquisition Corp. (Nasdaq: FLFV)CEO (Mar 2022–Jun 2024); Director (Jun 2022–Jun 2024)2022–2024Direct SPAC leadership and deal process experience .
US Tiger Securities, Inc.Managing Director, Head of Capital Markets2020–2024ECM/DCM execution; sponsor/PIPE networks .
Weitian Group LLCFounder, President2012–2020Corporate advisory/IR; issuer communications and investor targeting .
Merriman Capital, Oppenheimer, Ladenburg Thalmann, Ticonderoga, Pacific CrestEquity research/analyst roles2008–2016Coverage of China/tech sectors; analytical rigor and sector networks .

External Roles

OrganizationCapacityNotes
Snail, Inc. (SNAL)Co-CEOConcurrent operating role since April 2024 .
Kingswood Capital PartnersManaging DirectorConcurrent investment banking role .
Inkstone Feibo Acquisition Corporation (Inkstone SPAC)CFO and DirectorAdditional SPAC governance/finance experience .
Feutune Light Acquisition Corp. (FLFV)Former CEO/DirectorSPAC leadership track record (ended June 2024) .

Fixed Compensation

None of Aimfinity’s executive officers or directors, including Mr. Tian, has received any cash compensation (salary, bonus, or cash retainers) for services rendered prior to completion of an initial business combination; only out-of-pocket expense reimbursement is permitted and reviewed quarterly by the Audit Committee .

MetricFY 2022FY 2023FY 2024
Base Salary ($)$0 $0 $0
Target/Actual Bonus ($)$0 $0 $0
Cash Director Fees ($)$0 $0 $0

Performance Compensation

Aimfinity discloses no annual cash incentive plan, no RSU/PSU program, and no option grants to executives/directors prior to a business combination; compensation, if any, may be determined by the post-combination board/compensation committee after closing .

Incentive TypeMetric(s)WeightingTargetActual/PayoutVesting
Annual Cash BonusNot applicable
RSUs/PSUsNot applicable
OptionsNot applicable

Founder Shares are the primary equity incentive for insiders and are discussed in Equity Ownership & Alignment. Founder equity becomes worthless upon liquidation, creating a strong incentive to close a deal .

Equity Ownership & Alignment

ItemDetail
Beneficial Ownership100,000 Class B “Founder Shares” (approx. 5.0% of Class B) via Sponsor membership interest; Mr. Tian holds 5.908% of Sponsor membership interests entitling him to distribution of 100,000 founder shares .
Acquisition TermsMr. Tian purchased 5.908% of Sponsor membership interests on Jan 19, 2024 for $1,242, entitling him to 100,000 founder shares distribution .
Vested vs. UnvestedFounder shares convert to Class A upon business combination; founder shares are worthless if no business combination (deal-contingent value) .
Lock-Up/TransferFounder shares and private placement units remain subject to Letter Agreement lock-up restrictions per S-1 framework (company disclosure references applicable lockup) .
Options/WarrantsBeneficial ownership tables exclude warrants not exercisable within 60 days; no executive option grants disclosed .
Pledging/HedgingNo pledging disclosed in beneficial ownership or related party sections; no hedging policy disclosure observed .
Ownership GuidelinesNo executive/share ownership guidelines disclosed .

Employment Terms

TermStatus
Role Start DateMarch 17, 2023 (appointed CFO; also Class III director) .
Term/ExpirationOfficers serve at the discretion of the Board; no fixed term .
Severance / TerminationNo agreements providing benefits upon termination prior to business combination .
Change-of-ControlNot disclosed .
Non-Compete / Non-SolicitNot disclosed .
Garden Leave / Post-Termination ConsultingNot disclosed .
ClawbackNot disclosed .

Board Governance

  • Board Service: Director since March 17, 2023; appointed Class III director concurrent with CFO appointment .
  • Committee Roles: Audit Committee members are independent directors Kevin Vassily (Chair), Hanzhong (Han) Li, and Teng-Wei Chen; Mr. Tian is not listed on any committee .
  • Independence: Company identifies the Audit Committee as independent; Mr. Tian is a management director and not among independent committee members .
  • Lead Independent / Attendance: Not disclosed .

Director Compensation

  • No cash compensation or director fees paid prior to business combination; reimbursement only for out-of-pocket expenses with quarterly Audit Committee review .

Related Party and Incentive Structure Considerations

  • Founder Shares/Deal Incentives: Insiders’ founder shares become worthless if no business combination is completed within the prescribed timeline; Board acknowledges these interests may influence motivations in pursuing a deal .
  • Insider Voting Control: Insiders owned ~66.4% of outstanding Ordinary Shares as of record date and planned to vote in favor of extension proposals, highlighting concentrated control during key decisions .
  • Sponsor Financing: Working capital loans from the CEO-controlled Sponsor are convertible into private placement units at $10 upon business combination (structural dilution if converted), illustrating additional insider economic alignment with closing a deal .

Compensation Structure Analysis

  • Cash vs. Equity Mix: 100% pre-close compensation is non-cash; no salary/bonus. Economic upside is primarily via founder shares that are contingent on closing a business combination .
  • Pay-for-Performance Alignment: While founder shares tie value to deal completion, they can create incentives to consummate any transaction rather than optimize long-term quality, a risk noted by the company’s disclosure of insider interests diverging from public shareholders .
  • Year-over-Year Changes: No change in pre-close cash compensation structure across FY 2022–2024; no option/RSU programs disclosed .
  • Repricing/Modifications: No equity award repricings or modifications disclosed .

Performance & Track Record

  • Company Operating Profile: SPAC with no revenue and losses since inception; capital preserved in Trust Account for redemptions and business combination .
  • Capital/Shareholder Base Context: ~$14.29 million in Trust as of Sep 29, 2025; estimated ~$12.80 per-share redemption amount; extensive redemptions and repeated extensions emphasize the time pressure under which management operates .
  • Regulatory/Listing Constraints: Company has sought extensions and NTA requirement amendments to facilitate business combination (Docter) and navigate listing/penny-stock constraints—factors shaping execution risk during Mr. Tian’s tenure .

Equity Ownership & Alignment (Detail Table)

MetricValue
Class B Founder Shares Beneficially Owned100,000 shares (approx. 5.0% of Class B) .
Ownership FormIndirect via 5.908% Sponsor membership interests; purchased Jan 19, 2024 for $1,242 .
Economic ContingencyFounder shares become worthless if no business combination is completed .
Lock-Up/RestrictionsSubject to Letter Agreement/lock-up restrictions as disclosed .
PledgingNo pledging disclosed .

Employment Terms (Detail Table)

ItemDetail
Start DateMarch 17, 2023 (CFO and director) .
TermAt Board’s discretion; officers serve without fixed terms .
Severance / CoCNone disclosed; no termination benefits agreements pre-close .

Board Service History and Committee Roles

AttributeDetail
Board Class/StartClass III Director since Mar 17, 2023 .
CommitteesNot a member; Audit Committee consists of independent directors (Vassily—Chair, Li, Chen) .
IndependenceNot identified as independent; acts in management capacity; not on independent committees .

Investment Implications

  • Alignment and Pressure: Mr. Tian’s founder-share exposure provides strong financial alignment to complete a business combination but also creates pressure to transact (deal-contingent value that becomes worthless on liquidation) . For trading, milestones around extensions/redemptions and any definitive merger progress can be catalysts given insider voting control (~66.4%) and Trust dynamics .
  • Limited Pre-Close Cash Pay and No Variable Plan: Absence of salary/bonus reduces cash burn but offers little visibility into future incentive metrics until after any business combination, shifting focus to sponsor economics, lock-ups, and potential dilution from convertible insider financing .
  • Governance Considerations: Dual role as CFO and director, with no service on independent committees, concentrates influence in management and underscores the importance of independent Audit Committee oversight during the deal process .
  • Execution Risk: As a SPAC with no operations/revenue, outcome is binary around deal completion and listing/CFIUS/“penny stock” rule navigation; Mr. Tian’s capital markets and prior SPAC leadership experience is relevant but does not eliminate structural risks tied to redemptions, Trust size, and regulatory listing thresholds .